. HPV16 mRNA expression profiles in HNSCC map to early transcripts encoding E6 and E7. Related to Figure 1. (A) Raw RNAseq read counts aligned to the PaVE database HPV16 reference genome. Top, raw read count coverage is graphed for HPV(+) HNSCC samples with median E6 (unspliced) coverage > 100.51 counts (n = 53). Bottom, illustration of the HPV16 genome with position of the early promoter indicated, boxes highlighting open reading frames for the E6 (blue) and E7 (red) oncogenes, and select alternatively spliced HPV16 mRNAs translated to E6 or E7.
(B) Log10 (raw read counts) aligned to HPV16 genome from position 0 to 500 were used to discriminate between unspliced E6 and alternatively spliced E6*I (translated to E7) transcripts. Solid black lines represent the splice junction at position 227 and 408. Each HPV(+) HNSCC sample is plotted in a separate panel. Plots shown for selected HPV(+) samples were used to analyze the ratio between the mean of mapped reads flanking unspliced sequences (nt 226-227 and 408-409) versus the mean of mapped reads spanning the alternatively spliced region (nt 226^409). Representative BLI images of iLumiFluor and control littermates comparing TAM dose and delivery (i.l.
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versus i.p.) 10 days following last TAM injection. Animals administered TAM 5x i.p. displayed increased bioluminescent signals in off-target, non-fur bearing tissues (n = 5). 
